Treatment of cutaneous leishmaniasis with thymol loaded chitosan gel
Phase 2
Recruiting
- Conditions
- Cutaneous leishmaniasis.Cutaneous leishmaniasisB55.1
- Registration Number
- IRCT20180526039848N1
- Lead Sponsor
- Mashhad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
There are at least two lesions, in one case intervention + glucantime and in the other lesion only glucantime is prescribed.
15 to 60 years
Skin lesions at least one centimeter in size
Leishmaniasis confirmed by a parasitologist
consent signature
Exclusion Criteria
People who do not use the drug according to the plan
People who do not go to the clinic on the scheduled days
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Measuring the lesion diameter (millimeters) using image processing software. Timepoint: From the first week of treatment and patient visit the clinic for the first time (once every three days to 45 days). Method of measurement: processing software.
- Secondary Outcome Measures
Name Time Method